Christopher Posner, President and CEO: Tvardi Therapeutics TVRD Sell · Filed 24/02/12

Trade details

Type: Insider sale
Amount: $18,854.75
Shares · price: 35,575 sh · $0.53 a share
Held after: 186,355 sh
Stock: Tvardi Therapeutics TVRD
Person: Christopher PosnerPresident and CEO
Trade date: 24/02/08
Filed: 24/02/12
Days to filing: 4 days

Sold 16.0% of holdings

Share of holding sold: 16.0%

Tvardi Therapeutics trades, last 26 weeks

What else happened in Tvardi Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/09~24/03/09

Christopher Posner's recent trades

Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$2,769
583 sh
$2,769
Filed 25/03/04
Traded 25/02/28
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,756
372 sh
$1,756
Filed 25/02/06
Traded 25/02/04
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,064
3,668 sh
$1,064
Filed 24/11/06
Traded 24/11/04
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$1,452
4,149 sh
$1,452
Filed 24/08/02
Traded 24/08/01
Christopher PosnerPresident and CEO
SellTvardi Therapeutics
Sell
Tvardi Therapeutics
TVRD
$2,952
3,936 sh
$2,952
Filed 24/05/06
Traded 24/05/02